All News

    The Start of 2022 Sucked, But I'm Slowly Getting 'Back in the Race'

    April 14th 2022

    Early 2022 was difficult for me, with the death of my dog and some difficult cancer-related situations, but thankfully, I know wonderful people who helped pull me out of my slump.

    Targeted Therapy Advances in Lung Cancer Space Over Past 2 Decades 'Simply Remarkable'

    April 14th 2022

    Over the past 20 years, advancements in the lung cancer space have led to a drastic paradigm shift in how patients are now treated, ultimately leading to substantial improvements in survival and patient quality of life.

    FDA Speeds Up Development of New Metastatic Breast Cancer Treatment

    April 14th 2022

    The Food and Drug Administration granted a fast-track designation to Bria-IMT for the treatment of patients with metastatic breast cancer.

    Clinical Trial Assessing Keytruda-Investigational Drug Combo in Head and Neck, Bladder and Lung Cancer Doses First Patient

    April 13th 2022

    Investigators plan to enroll approximately 90 patients with squamous cell carcinoma of the head and neck, as well as metastatic bladder and non-small cell lung cancer.

    FDA’s Approval of Opdivo-Chemo Regimen Spurs Another Thought-Provoking Treatment Option in Lung Cancer

    April 13th 2022

    The FDA’s recent approval of Opdivo plus chemotherapy may be beneficial for some patients with non-small cell lung cancer, further highlighting the need for multidisciplinary care.

    Has Cancer Survivorship Made Me Weak?

    April 13th 2022

    After surviving cancer, I’ve developed complex post-traumatic stress disorder, which comes with feelings of insecurity and anger.

    A New Path Emerges in Lung Cancer Treatment

    April 13th 2022

    Anti-TIGIT immunotherapy drugs may improve quality of life and survival, while being well tolerated by patients.

    BCMA-Targeted Drugs Allow for a ‘More Targeted Killing’ of Myeloma Cells

    April 13th 2022

    In recent years, BCMA-targeted therapies have changed the landscape of relapsed/refractory myeloma treatment, filling a previously unmet need.

    FDA Places Partial Hold on Trial Investigating Novel Drug in Patients With Leukemia and Lymphoma

    April 12th 2022

    The FDA’s partial hold means that no new patients with either leukemia or lymphoma can be enrolled onto the trial.

    Risk Factors to Consider Before Breast Reconstruction Surgery

    April 12th 2022

    Anemia and anticoagulant use were both associated with higher blood loss and drainage volume, which may prolong a hospital stay after breast reconstruction surgery, according to recent study results.

    When Another Friend Dies of Cancer, I Ask Myself, ‘What Quirk of Fate Left Me Here?’

    April 12th 2022

    As I prepared for my friend’s celebration of life, I reflected on other loved ones I lost to cancer and pondered why I am lucky enough to survive.

    KRAS G12C Lung Cancer: New Therapies Treat the 'Undruggable'

    April 12th 2022

    The KRAS G12C gene mutation in non-small cell lung cancer has been deemed “undruggable,” but recent effective therapies have successfully targeted this mutation, leading to shrinking of tumors and longer survival.

    Post-Treatment Venclexta Improves Outcomes and Is Well-Tolerated in CLL

    April 12th 2022

    Regardless of whether it was guided by minimal residual disease status or given at a fixed dosage, consolidation Venclexta proved to be beneficial in patients with chronic lymphocytic leukemia.

    Finding Someone You Trust: Cancer Hope Network Advocate Highlights Programs Available for Patients with Lung Cancer

    April 11th 2022

    As part of its Speaking Out video series, CURE spoke with Sarah Miretti Cassidy, director of external affairs at Cancer Hope Network, about the importance of support following a lung cancer diagnosis.

    Advocate Discusses Emotional Side Effects from Lung Cancer, and the Types of Support Available to Help

    April 11th 2022

    As part of its Speaking Out video series, CURE spoke with Sarah Miretti Cassidy, director of external affairs at Cancer Hope Network, about the psychosocial effects of a lung cancer diagnosis.

    Caring for the Caregiver: Seeking Support Through Cancer Hope Network

    April 11th 2022

    As part of its Speaking Out video series, CURE spoke with Sarah Miretti Cassidy, director of external affairs at Cancer Hope Network, about support for caregivers of patients with lung cancer.

    Advocate Discusses Types of Support for End-Stage Cancer Available for Patients and Their Loved Ones

    April 11th 2022

    As part of its Speaking Out video series, CURE spoke with Sarah Miretti Cassidy, from Cancer Hope Network, about seeking support for patients who may be nearing end of life, as well as support for family and friends after a loved one has passed.

    Next-Generation Sequencing Is ‘Treatment Changing’ for Cancer — But What Is It?

    April 11th 2022

    “It’s important for patients to be educated on (next-generation sequencing), because the more we know about a patient’s cancer, the better we can design a personalized treatment plan,” says an expert.

    Art Can Be an ‘Outpouring of What’s Pent Up’ for Cancer Survivors

    April 11th 2022

    While wandering around an outdoor art exhibit, I found a sculpture that really spoke to my cancer experience.

    COVID-19 and Cancer May Disproportionally Affect Black Patients Compared With Others

    April 11th 2022

    The results, according to the study authors, may highlight a bigger issue related to structural racism in health care.

    Meat Intake May Not Impact Risk of Disease Recurrence, Death in Colon Cancer

    April 11th 2022

    Patients with stage 3 colon cancer who consume processed meat or unprocessed red meat after receiving their diagnosis may not be at an increased risk for cancer recurrence or death.

    Navigating Cancer Test Results Is Challenging for Patients and Their Caregivers

    April 10th 2022

    When my late wife was diagnosed with BRCA2-related triple-negative breast cancer, I realized how important medical literacy is for patients and their loved ones.

    Educated Patient® Multiple Myeloma Summit New Therapies on the Horizon Panel: March 12, 2022

    April 9th 2022

    Watch Kristie L. Kahl, with Sham Mailankody, MBBS; Cesar Rodriguez, MD; and Lynn Steele, discuss new therapies on the horizon, during the CURE Educated Patient Multiple Myeloma Summit.

    Highlights from CURE's Educated Patient Multiple Myeloma Summit

    April 8th 2022

    Here are some key takeaways from the CURE® Educated Patient® Multiple Myeloma Summit.

    Newfound Sense of Empathy Makes Cancer Survivor ‘Feel More Human’

    April 8th 2022

    After surviving cancer and the many bad days that come with a diagnosis, voice actor Rob Paulsen noted that he had a newfound sense of empathy that helped him out of some of his darkest days.

    Inclusion in Cancer Care Takes an Effort on All Fronts

    April 8th 2022

    As a melanoma advocate, I realized that people of color often are not included in research or properly understand their risks for skin cancer. Here’s what I’m doing to change that.

    Cancer Survivor to Run Boston Marathon Alongside His Organ Donor, HIV Drug Shows Promise in Treating Metastatic Colon Cancer and More

    April 8th 2022

    From liver cancer survivor planning to run the upcoming Boston Marathon with his organ donor to a common HIV drug showing promise in treating colorectal cancer, here’s what’s happening in the cancer space this week.

    Educated Patient® Multiple Myeloma Summit Upcoming FDA Approvals Presentation: March 12, 2022

    April 8th 2022

    Watch Dr. Cesar Rodriguez, of the Multiple Myeloma Program at the Ichan School of Medicine at Mount Sinai, discuss upcoming FDA approvals in the space, during the CURE Educated Patient Multiple Myeloma Summit.

    Trial of Direct-to-Tumor Skin Cancer Drug Doses First Patient

    April 7th 2022

    A phase 2 trial will investigate LTX-315 in patients with basal cell carcinoma, the most common form of skin cancer.

    Sentinel Node Biopsies ‘Not Likely to Have a Major Impact’ on Outcomes for Older Women With Breast Cancer

    April 7th 2022

    The presence of cancer in the lymph nodes may not be the strongest indicator of the need for adjuvant chemotherapy in older women with breast cancer, according to recent study results.

    NEXT PAGE
    PREVIOUS PAGE